Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 7;168(2):53.
doi: 10.1007/s00705-022-05628-y.

Coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus during the COVID-19 pandemic

Delsuz Rezaee  1 , Somaye Bakhtiari  2   1 , Farid Azizi Jalilian  2 , Amin Doosti-Irani  3 , Fatemeh Torkaman Asadi  4 , Nastaran Ansari  5   6
Affiliations

Coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus during the COVID-19 pandemic

Delsuz Rezaee et al. Arch Virol. .

Abstract

The prevalence of coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus among referred patients in Hamadan province, Iran, from November 2, 2021, to January 30, 2022, was evaluated. Samples were obtained from 14,116 individuals with COVID-19 symptoms and screened for SARS-CoV-2 and influenza viruses using a multiplex real-time PCR panel assay. Of these patients, 14.19%, 17.11%, and 1.35% were infected with influenza virus, SARS-CoV-2, and both viruses, respectively. The majority of the coinfected patients were female outpatients aged 19-60 years.

Keywords: COVID-19; Coinfection; Influenza; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

References

    1. Alosaimi B, Naeem A, Hamed ME, Alkadi HS, Alanazi T, Al Rehily SS, Almutairi AZ, Zafar A. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J. 2021;18:1–9. doi: 10.1186/s12985-021-01594-0. - DOI - PMC - PubMed
    1. Yue H, Zhang M, Xing L, Wang K, Rao X, Liu H, Tian J, Zhou P, Deng Y, Shang J. The epidemiology and clinical characteristics of co-infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreak. J Med Virol. 2020;92:2870–2873. doi: 10.1002/jmv.26163. - DOI - PMC - PubMed
    1. Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020;132:749–755. doi: 10.1080/00325481.2020.1786964. - DOI - PubMed
    1. Konala VM, Adapa S, Gayam V, Naramala S, Daggubati SR, Kammari CB, Chenna A. Co-infection with Influenza A and COVID-19. Eur J Case Rep Intern. 2020;7:001656. doi: 10.12890/2020_001656. - DOI - PMC - PubMed
    1. Cox MJ, Loman N, Bogaert D, O'Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020;1:e11. doi: 10.1016/s2666-5247(20)30009-4. - DOI - PMC - PubMed